Streetwise Reports' Article Archives — January 2020 back to current month (142)
The compelling aspects of this life sciences story are presented in a Dawson James report.
Target Price Raised on Red Lake Gold Explorer (01/31/2020)
An operations update on one of the company's projects is provided in an Echelon Wealth Partners report.
The military branch intends to "evaluate and learn how to deploy the platform for personnel and asset protection at ports of call around the world."
The company's robust Q4/19 and outlook for this year are addressed in a Raymond James report.
Getchell Wins the Nevada Lotto (01/31/2020)
Bob Moriarty of 321gold discusses a junior explorer that has taken on two major gold properties in Nevada.
Syndax Pharmaceuticals' shares traded 30% higher after the company reported it expects to raise $35 million from a common stock offering from five institutional investors and secured a $30 million non-dilutive term loan facility.
The company makes the changes to manage its "broad and responsible approach to advancing projects with community support."
The company makes progress getting its products approved and sold in more countries.
IP Survey Results at Nevada Project Detect Anomalies (01/30/2020)
Preliminary findings show the presence of sulphides at depth on the property.
Arcadia Biosciences shares traded 25% higher after reporting that it secured $3 million in pre-season GoodHemp seed purchase commitments in just 50 days after launching the product.
Oil & Gas Services Company Upgraded to Buy (01/30/2020)
The reasons behind the changed rating and expectations for the firm's Q4/19 are presented in an iA Securities report.
The compelling aspects of this investment opportunity are outlined in a Pareto Securities report.
The results will help guide the company's future exploration there.
Energy Storage Systems Firm Reviews FY19 Highlights (01/29/2020)
Fourth quarter revenue increases 693% year over year.
Two Approvals Underscore Biotech's Pipeline Quality (01/29/2020)
The green lights and their implications are discussed in an H.C. Wainwright & Co. report.
Shares of Accuray traded 15% higher today after the company reported Q2/20 financial results.
According to the company, the findings indicate potential for further extension of the mineralization there.
The factors contributing to the company's status and financial expectations for this year are discussed in a Raymond James report.
Fund manager Adrian Day writes about junior exploration companies in his portfolio that he is recommending for purchase.
Peter Epstein of Epstein Research discusses recent developments at the company.
The companies will combine their technologies into products aimed at transforming the corporate learning and development industry.
Acceleron Pharma's shares established a new 52-week high after the company reported that sotatercept achieved both primary and secondary endpoints in the Phase 2 PULSAR study in patients with pulmonary arterial hypertension.
Bob Moriarty of 321gold sits down with Maurice Jackson of Proven and Probable to discuss geopolitics, precious metal prices and precious metal stocks.
The chief geologist believes the deposits are part of a large, emerging trend.
The company's vice president was recognized for her role in advancing a deposit in Nevada.
Malevolent Microbes (01/27/2020)
Sector expert Michael Ballanger examines the possible effects the emergence of the coronavirus in China may have on markets, and offers his observations on January's market performances.
Inovio Pharmaceuticals' shares rose 30%, setting a new 52-week high price, after the firm reported it received a grant of up to $9 million to develop a vaccine against the coronavirus.
More Details on Private Placements (01/27/2020)
In part three of the series, "All About Private Placements," Maurice Jackson of Proven and Probable talks with Tekoa Da Silva, a financial adviser with Sprott USA, about details of private placements, including removing restrictive legends, exercising warrants, timing of private placement tranches, and understanding corporate share structures.
Bob Moriarty of 321gold reflects on how government actions in the financial and public health spheres will pop market bubbles.
Infill drilling continues to further optimize the economics outlined in the study.
These results could improve the project's economics and indicate bulk mining is possible there, according to the company.
The company continues to evolve this digital offering as well.
The product contains the firm's OxC-beta™ supplement.
The system should generate $1.3 million-plus in energy revenue during its 25 years in operation.
Imaging System Developer Outlines Plan for 2020 (01/24/2020)
The company continues to advance its device toward commercialization.
On-site implementation is scheduled to begin shortly.
Company has noted that drilling has confirmed the presence of structures and stratigraphy similar to neighboring Turquoise Ridge and Twin Creeks gold mines.
The Critical Investor profiles one of the few companies in the region whose Environmental Impact Assessment has been approved.
Technical analyst Clive Maund examines this potential of the company's stock.
Online medical exchange operator eHealth Inc.'s shares traded higher after the firm reported preliminary financial results for Q4/19 and FY/19. The company advised that both quarterly and annual revenues exceeded prior estimates.
Andy Schectman of Miles Franklin Precious Metals Investments and Maurice Jackson of Proven and Probable discuss investment strategies centered on precious metals ratios.
Molecular diagnostics company Co-Diagnostics' shares opened more than 144% higher after the firm reported it has designed a test for virus detection of the new coronavirus, 2019-nCoV, using its CoPrimer™ platform.
Peter Epstein of Epstein Research provides an update on a company with a lithium project in Arkansas.
The Critical Investor provides an update on this explorer's Indiana project in Chile.
New results include long, high-grade polymetallic intervals.
This new business segment will be developed for in-store retail.
Millennial Lithium: Full Speed Ahead (01/22/2020)
With initial production at its Argentina project expected in 2022, Peter Epstein of Epstein Research believes the company could be an "excellent" bet when lithium prices rebound.
Neurotrope's shares traded higher today after reporting results from its Phase 2 "203" clinical trial of Byrostatin-1 for treatment of moderately severe to severe Alzheimer's patients. The firm has also been awarded a $2.7 million grant from the National Institutes of Health to conduct additional clinical research for patients with advanced Alzheimer's disease.
Also, the exploration company is working to accelerate drilling at the property.
The companies aim to build, certify and distribute complete proprietary storage solutions for residences.
Low acquisition and exploration costs and high-grade sampling are some of the reasons why two industry observers have a Buy rating on this company.
An update on the project and its production is provided in a Haywood report.
Explorer 'On the Road to Production' (01/21/2020)
The next steps for the precious metals company are provided in a ROTH Capital Partners report.
Biopharma Shows 'Good Start to 2020 News Flow' (01/21/2020)
The two developments that already took place this year are addressed in an H.C. Wainwright & Co. report.
The work is scheduled to begin later this month.
Genprex's shares spiked 380% higher in morning trading as the company reported that the FDA granted Fast Track Designation for its Oncoprex immunogene therapy in combination with EGFR inhibitor osimertinib.
Silver Update: Expect a Price Decline (01/20/2020)
Technical analyst Clive Maund charts silver and predicts a small drop in the price of the metal.
InMed Pharmaceuticals shares traded 25% higher after reporting that it is the first to advance cannabinol into therapeutic clinical trials.
Gold Update: May Retreat Before Next Upleg (01/20/2020)
Technical analyst Clive Maund looks at the charts and finds that gold may react back before continuing to climb.
The Only 'Bubble' That Counts (01/20/2020)
Sector expert Michael Ballanger considers the last week in the stock and precious metals markets.
Palladium Miner Shows Promise (01/20/2020)
Given current market conditions, the location and potential of its flagship project, and the strength of its management team, Ron Struthers of Struthers' Resource Stock Report believes this firm represents a solid investment.
'High-Grade Gold' Unearthed at Mexican Site (01/20/2020)
Drill results for this company's prospect, flanked by notable mines, is the subject of this interview with Proven and Probable's Maurice Jackson.
Viscount Likes a Lot of Silver (01/19/2020)
Bob Moriarty of 321gold explains why he has invested in this silver explorer with a project in Colorado.
Gold Miner Returns Multiple High-Grade Results (01/18/2020)
Both targets being reported demonstrate upside potential of the asset.
The current program at the British Columbia property has only "scratched the surface."
The report projects a 55% pretax and 50% post-tax internal rate of return at US$55 per pound uranium.
This new business segment for the firm offers growth potential.
In 2020 the company intends to refocus on growth and profitability.
With this program, the Canadian company will follow up on positive drill results from 2019.
The explorer that owns the asset reports the final results of its 2019 core drill program.
After opening flat today, shares of Platinum Group Metals Ltd. climbed to a new 52-week high price fueled by high demand and increases in platinum group metals prices. The firm claims its primary objective is now the advancement of the palladium dominant Waterberg Project in South Africa.
The transaction will expand the company's portfolio of properties.
Rare Earths Company Outlines 2020 Project Goals (01/16/2020)
All of the firm's aims center on rapidly advancing its deposit in Canada.
Explorer to Buy Adjacent Red Lake Property (01/16/2020)
Though never drill tested, the company believes the area is highly prospective for gold.
The company provided an operational update and plan for the project.
The specifics of both moves are presented in an iA Securities report.
Miner Is 'Set Up for a Strong 2020' (01/16/2020)
The numbers from the company's three operations are reviewed in a CIBC report.
The potential of this company's asset is discussed in an Echelon Wealth Partners report.
The Critical Investor sits down with Rick Rule, CEO of Sprott U.S. Holdings, for a wide-ranging discussion of his more than four-decade-long involvement in the resource sector.
Shares of NantKwest Inc. spiked as much as 85% higher in mid-morning trading setting a new 52-week high price after the company reported a series of positive results at the 38th J.P. Morgan Healthcare Conference in San Francisco. The firm reported that complete responses were noted in as many as six different multiple tumor types when "natural killer" cells and T cells are activated simultaneously.
In conversation with Maurice Jackson of Proven and Probable, the CEO elaborates on what could be a "company-making" event.
Details of the arrangement and an update on the company's pipeline are provided in a Dawson James report.
Pope Resources LP shares set a new 52-week intraday high price today after the timber resources firm announced that it agreed to be acquired by Rayonier for $554 million, or $126.91 per unit. The transaction is expected to close in mid-year 2020 subject to approval of Pope's unitholders and customary regulatory approvals.
Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy.
The report updates and the company being a takeout target are discussed in an iA Securities report.
The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.'
The transaction brings numerous existing partnerships and digital technologies.
The Vancouver-based company believes it may have discovered a new mineralized zone at a British Columbia property.
The services will consist of preparing three-dimensional AR representations of the exploration company's core samples.
Shares of Transenterix opened 50% higher after the company reported that it has submitted a 510(k) submission to the FDA for the first machine vision system for use in robotic surgery.
Group Ten Delivers World-Class Drill Results for PGM (01/14/2020)
Bob Moriarty of 321gold reports on the latest drill results from this company's Montana project.
Visionary Vicissitude (01/13/2020)
Sector expert Michael Ballanger offers his insights into the precious metals markets as 2020 begins.
Technical analyst Clive Maund examines the effects of recent geopolitical events on the precious metals markets.
Shares of Adaptimmune Therapeutics more than tripled in value after the company reported that its SPEAR T-cell platform delivered positive initial responses in four different solid tumor indications.
Technical analyst Clive Maund charts silver's progress in comparison to gold's following recent world events.
As such, enterprises using the VMS have access to independent, talent acquisition experts.
The added project entails installing a solar energy solution at an additional customer site.
Telemedicine Tech Firm Garners Five New US Clients (01/10/2020)
With these contracts, the company extends its geographic footprint to an additional county.
Life Sciences Firm Upgrades to OTCQB Venture Market (01/10/2020)
This is a significant achievement of this developing company.
In doing so, it gets one step closer to market approval from U.S. regulators.
Rare disease biopharmaceutical company Ultragenyx Pharmaceutical's shares traded 30% higher after the firm reported positive topline results from Cohorts 2 and 3 in its Phase 1/2 study of DTX301 gene therapy in Ornithine Transcarbamylase Deficiency.
The work the company has conducted to date at the project and the implications are discussed in a Scarsdale Equities report.
The program targeted a historical mine at the explorer's Nevada project.
Uranium-Vanadium Company Provides Updates (01/09/2020)
The firm will attend the Vancouver Resource Investment Conference 2020.
All permits are in hand, and the drill rig will be mobilized soon.
Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and meaningful improvements in central visual sensitivity and advised that it plans to initiate a pivotal trial by year-end 2020.
The near-term events expected to trigger movement of the biotech's share price are outlined in a ROTH Capital Partners report.
Palladium-Copper Project PEA Shows Robust Economics (01/08/2020)
The study suggests a low-cost mining operation at the Ontario property is possible.
The Canadian company reports new results from its 2019 drill campaign.
The owner of the asset ascertained this from new drill results.
Q4/19 revenue is up 4,390% since the same time in the previous year.
This expansion follows the successful partnership in Calgary.
Brent Cook: Investors Should Get Boots on the Ground (01/08/2020)
In this interview with Maurice Jackson of Proven and Probable, Exploration Insights' Brent Cook discusses the value of site visits to determining the potential of a prospect, and offers insights into various metals markets.
Applied Therapeutics' shares traded 25% higher today after the company reported positive topline results from its Pivotal Phase 2 ACTION Study of AT-007 for use in the treatment of galactosemia. The firm expects to file for regulatory approval of AT-007 in H2/20.
The energy company is now conducting fluid flowback at the Texas well.
Bill Powers of Mining Stock Education sits down with Kevin Drover, CEO of Aurcana, to talk about the company's production plans for its high-grade project in Colorado.
The merger is expected to foster growth of both entities.
The funds are to see the company through its transition to contract manufacturing.
The year included achievements related to exploration and finances.
Maurice Jackson of Proven and Probable and Jayant Bhandari of Capitalism and Morality talk about the dangers posed by education, prosperity and democracy to economic stability and the accumulation of wealth.
Shares of Apellis Pharmaceuticals opened 35% higher and established a new 52-week intraday high price today after the company announced positive top-line results from its Phase 3 head-to-head study of Pegcetacoplan (APL-2) versus Eculizumab in patients with Paroxysmal Nocturnal Hemoglobinuria.
Fund manager Adrian Day reviews recent developments with precious metals producers in his portfolio.
Peter Epstein of Epstein Research profiles this explorer and explains why he believes it could be a take-out target.
Silver Update: Likely to Back Off Short Term (01/06/2020)
Technical analyst Clive Maund discusses recent movements in the price of silver.
Ron Struthers of Struthers Resource Stock Report profiles a small-cap whose device changes electromagnetic radiation to a benign state.
aTyr Pharma's shares traded 45% higher today after the firm reported that it had entered into a collaboration agreement with Kyorin Pharmaceutical for development and commercialization of its ATYR1923 drug in Japan.
Bob Moriarty of 321gold discusses the highly anticipated drill program at the Pueblo Grande property.
Technical Analyst: Gold at Resistance Level (01/06/2020)
Technical analyst Clive Maund discusses the effects of geopolitics on the price of gold.
These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report.
The design of and an opinion on the included studies are provided in an H.C. Wainwright & Co. report.
The company, however, will continue to advance the same therapeutic in two other diseases.
The result and what it means for a neighboring energy firm are provided in a Pareto Securities report.
With sufficient funds in place, the Vancouver-based company intends to start exploring the property this year.
Shares of Leap Therapeutics jumped 60% after the company reported that it signed an exclusive option and license agreement for its immuno-oncology drug DKN-01 with BeiGene in the Asia Pacific region excluding Japan. The firm also secured an additional $27 million in equity financing from BeiGene and two other investment groups.
Gold Producer to Sell Interest in Founding Asset (01/02/2020)
The transaction is briefly reviewed and assessed in a BMO Capital Markets report.
Hi-yo Silver, Away! (01/02/2020)
Rick Mills of Ahead of the Herd breaks down the investment thesis behind his belief silver prices are poised to gallop ahead.
The agreement pertains to future gold-silver concentrate produced at the company's Mexican operations.
Explorer Closes Private Placement with Eric Sprott (01/02/2020)
The Canadian base and precious metals company will use the proceeds to explore its project in British Columbia.
TriStar Gold, Another Wits Lookalike in Brazil (01/02/2020)
Bob Moriarty of 321gold discusses the similarities between this project and the Witwatersrand deposit in South Africa.
Pulmatrix's shares opened 90% higher today after the firm reported that it has signed a kinase inhibitor licensing agreement with the Lung Cancer Initiative at Johnson & Johnson.
Augmented Reality Firm Inks Deal with Weby Corp. (01/02/2020)
Accordingly, the tech company will provide its e-commerce platform.
Fieldwork is being done on the property to further determine its upside potential.
|"SEA stock should do well in the coming bull market."|
|"We came away from a site visit to LIO's Tuvatu very impressed."|
|"TRCH debt holders converted the obligations into a working interest."|
|"We are initiating coverage on ELY with an Outperform rating."|
|"NTAR's business is still growing well on the e-commerce and AR sides."|